Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Brand Names
- Pedvaxhib, Vaxelis
- Generic Name
- Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
- DrugBank Accession Number
- DB10342
- Background
Haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen is a vaccine containing outer membrane antigen extracted from Haemophilus influenzae.
- Type
- Biotech
- Groups
- Approved, Investigational
- Biologic Classification
- Vaccines
Other vaccines - Synonyms
- Haemophilus influenzae b (Ross strain) capsular polysaccharide Meningococcal Protein Conjugate Vaccine
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Prevention of Invasive infection caused by haemophilus influenzae type b •••••••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image PedvaxHIB Injection, suspension 7.5 ug/0.5mL Intramuscular Merck Sharp & Dohme Llc 1989-12-20 Not applicable US 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Comvax Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen (7.5 ug/0.5mL) + Hepatitis B virus subtype ADW HBSAG surface protein antigen (5 ug/0.5mL) Injection, suspension Intramuscular Merck Sharp & Dohme Limited 1996-10-02 2016-08-19 US HEXAXIM 0.5 ML IM ENJEKSİYONLUK SÜSPANSİYON İÇEREN FLAKON, 1 ADET Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen (12 µg) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (25 µg) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (25 µg) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (40 IU) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (20 IU) + Hepatitis B Vaccine (Recombinant) (10 µg) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 D) + Poliovirus type 2 antigen (formaldehyde inactivated) (8 D) + Poliovirus type 3 antigen (formaldehyde inactivated) (32 D) Injection, solution Intramuscular SANOFİ PASTEUR AŞI TİC. A.Ş. 2017-07-18 2023-10-17 Turkey 
HEXAXIM 0.5 ML IM ENJEKSİYONLUK SÜSPANSİYON İÇEREN FLAKON, 10 ADET Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen (12 µg) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (25 µg) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (25 µg) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (40 IU) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (20 IU) + Hepatitis B Vaccine (Recombinant) (10 µg) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 D) Injection, solution Intramuscular SANOFİ PASTEUR AŞI TİC. A.Ş. 2017-07-18 2023-10-17 Turkey HEXAXIM 0.5 ML IM ENJEKSİYONLUK SÜSPANSİYON İÇEREN KULLANIMA HAZIR ENJEKTÖR, 1 ADET Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen (12 µg) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (25 µg) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (25 µg) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (40 IU) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (20 IU) + Hepatitis B Vaccine (Recombinant) (10 µg) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 D) Injection, solution Intramuscular SANOFİ PASTEUR AŞI TİC. A.Ş. 2017-07-27 Not applicable Turkey HEXAXIM 0.5 ML IM ENJEKSİYONLUK SÜSPANSİYON İÇEREN KULLANIMA HAZIR ENJEKTÖR, 10 ADET Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen (12 µg) + Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (25 µg) + Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (25 µg) + Clostridium tetani toxoid antigen (formaldehyde inactivated) (40 IU) + Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (20 IU) + Hepatitis B Vaccine (Recombinant) (10 µg) + Poliovirus type 1 antigen (formaldehyde inactivated) (40 D) Injection, solution Intramuscular SANOFİ PASTEUR AŞI TİC. A.Ş. 2017-07-27 Not applicable Turkey
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- LUY6P8763W
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Not Available Diphtheria / Haemophilus Infections / Pertussis / Poliomyelitis / Tetanus 1 somestatus stop reason just information to hide 4 Completed Prevention Diphtheria 1 somestatus stop reason just information to hide 4 Completed Prevention Haemophilus Influenzae Type b (Hib) Infection 1 somestatus stop reason just information to hide 4 Completed Prevention Hepatitis A Virus 1 somestatus stop reason just information to hide 4 Completed Prevention Hexavalent Vaccine / Vaccines, Combined 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, suspension Intramuscular Injection, solution Intramuscular Injection Intramuscular 10 µg Injection Intramuscular Injection, powder, for suspension Intramuscular Suspension Intramuscular Injection, suspension Intramuscular 7.5 ug/0.5mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53